ENCIFER

This brand name is authorized in Nigeria. It is also authorized in Ecuador.

Active ingredients

The drug ENCIFER contains one active pharmaceutical ingredient (API):

1	Iron sucrose UNII FZ7NYF5N8L - IRON SUCROSE
	Iron sucrose is composed of a polynuclear iron(III)-hydroxide core surrounded by a large number of non-covalently bound sucrose molecules. The polynuclear iron core has a structure similar to that of the core of the physiological iron storage protein ferritin. The complex is designed to provide, in a controlled manner, utilisable iron for the iron transport and storage proteins in the body (i.e., transferrin and ferritin, respectively).
	Read more about Iron sucrose

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
A4-2371	Injection	Encifer Injection INJ 100 mg/5 mL 5 X 5ml colorless glass ampoule	8 RNW-PP-115884 Encifer Injection Iron 100mg/5ml Sucrose Injection USP. (Iron III Hydroxide 100mg/5ml in sucrose) ferric hydroxide in complex with sucrose, Ferric hydroxide in complex with sucrose equivalent to elemental Iron 100 mg. Encifer: Each 5 mL contains Ferric hydroxide in complex with sucrose equivalent to elemental Iron 100 mg. The drug product contains approximately 30% sucrose w/v (300 mg/mL) and has a pH of 10.5-11.1. Encifer contains no preservatives. A4-2371 Drugs Imported Products 55ml colorless glass ampoule Prescription Only Medicine (POM) 1/24/2020 EMCURE NIGERIA LIMITED, 29 ADENIYI JONES AVENUE, IKEJA LAGOS 8037749701 emcurenigerialtd@gmail.com SamrudhPharmaceuticals Pvt Ltd, Plot J-174, J-188, J-168/1, MIDC, Tarapur, Boisar, Thane 401506, Maharastra, India, India	06/07/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
B03A	Iron preparations	B Blood and blood forming organs → B03 Antianemic preparations
Discover more medicines within B03A
B03AC	Iron trivalent, parenteral preparations	B Blood and blood forming organs → B03 Antianemic preparations → B03A Iron preparations
Discover more medicines within B03AC

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	28717-01-09
NG	Registered Drug Product Database	A4-2371